Where is AveXis headquartered?

AveXis is located in Bannockburn, IL.

Who invested in AveXis?

AveXis has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for AveXis?

AveXis closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

avexis.com

AveXis

AveXis develops and commercializes gene therapies for the treatment of neurological genetic disorders.

Business Model:

Revenue: $15M

Employees: 1,001-5,000

AveXis was acquired by Novartis.
The acquisition happend on 2018-04-09.
Details of the transaction were not public

Acquirer

Novartis

General Information

Geographic Data

Address: 2275 Half Day Road

City: Bannockburn

State: IL

Zip: 60015

Country: US

Financial Info

Stage:

grant

Raised Last:

$100k

Raised Total:

$75M

Social

Facebook

Twitter

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

AveXis develops and commercializes gene therapies for the treatment of neurological genetic disorders.

Contact Phone:
+18475728280

Contact Email:

IPO Details

AveXis went public on 2/11/2016 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
2/11/2016

IPO Valuation:
$430M

Ticker Symbol:
AVXS

IPO Price:
$20/share

Amount Raised:
$95M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
9/2015	Series D	12	$65M	QVT Financial Foresite Capital RA Capital Management Venrock Adage Capital Management Rock Springs Capital T. Rowe Price Deerfield Boxer Capital T. Rowe Price Janus Capital Group RTW Investments Roche Venture Fund QVT Financial Foresite Capital RA Capital Management Venrock Adage Capital Management Rock Springs Capital T. Rowe Price Deerfield Boxer Capital T. Rowe Price
4/2014	Series B		-
7/2013	Series A		-
8/2015	Series C		$10M	Deerfield Capital Management
3/2016	Equity		$500k
2/2016	IPO		$95M
1/2015	Series C	2	$10M	Deerfield Roche Venture Fund Deerfield Roche Venture Fund
1/2019	Grant	1	$100k	North Carolina Biotechnology Center North Carolina Biotechnology Center
4/2014	Series B		-
7/2013	Series A		-

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details